Akanda (AKAN) Cash & Equivalents (2020 - 2025)
Akanda's (AKAN) quarterly Cash & Equivalents came in at $503562.0 in Q4 2025, down 86.89% year-on-year from $3.8 million in Q4 2024, and down 80.05% quarter-over-quarter from $2.5 million in Q2 2025.
Akanda (AKAN) Cash & Equivalents (2020 - 2025) Analysis & Trends
Akanda's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $503562.0 for Q4 2025.
- On a quarterly basis, Cash & Equivalents fell 86.89% year-over-year to $503562.0 in Q4 2025; TTM through Dec 2025 was $503562.0, a 86.89% decrease from a year earlier, with the FY2025 full-year figure at $503562.0, down 86.89% from the prior year.
- Cash & Equivalents declined to $503562.0 in Q4 2025 per AKAN's latest filing, from $2.5 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $6.0 million in Q2 2024 and bottomed at $93875.0 in Q4 2023.
- The 5-year median for Cash & Equivalents is $2.5 million (2025), against an average of $2.3 million.
- Across the five-year window, Cash & Equivalents surged 25784.11% in 2021 and plunged 92.68% in 2022, its largest moves.
- Year by year, Cash & Equivalents stood at $3.5 million in 2021, then plunged by 92.68% to $255803.0 in 2022, then slumped by 63.3% to $93875.0 in 2023, then jumped by 3992.53% to $3.8 million in 2024, then plunged by 86.89% to $503562.0 in 2025.
- Per Business Quant, the three latest AKAN Cash & Equivalents figures stand at $503562.0 (Q4 2025), $2.5 million (Q2 2025), and $3.8 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.76 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.79 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.28 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 266.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | 503,562.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 503,562.00 |
| Jun 30, 2025 | 2.52 Mn |
| Dec 31, 2024 | 3.84 Mn |
| Jun 30, 2024 | 6.01 Mn |
| Dec 31, 2023 | 93,875.00 |
| Jun 30, 2023 | 443,338.00 |
| Dec 31, 2022 | 255,803.00 |
| Jun 30, 2022 | 3.93 Mn |
| Dec 31, 2021 | 3.50 Mn |
| Dec 31, 2020 | 13,504.00 |